NYSE - Nasdaq Real Time Price USD
Veeva Systems Inc. (VEEV)
Get in-depth analysis now
With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly.
189.18 -14.17 (-6.97%)
As of 12:25:24 PM EST. Market Open.
Chart Range Bar
Loading chart for VEEV
News headlines Veeva Systems (VEEV) faces a mixed outlook as analysts give it a Strong Buy average rating, but recent stock performance raises concerns. The company shows strong growth metrics, yet its valuation appears stretched amid market volatility.
Veeva Systems (VEEV) faces a mixed outlook as analysts give it a Strong Buy average rating, but recent stock performance raises concerns. The company shows strong growth metrics, yet its valuation appears stretched amid market volatility.
Updated 17m ago · Powered by Yahoo Scout
- Previous Close
203.35 - Open
200.27 - Bid 190.10 x 12000
- Ask 190.16 x 16000
- Day's Range
188.61 - 201.15 - 52 Week Range
188.61 - 310.50 - Volume
1,922,877 - Avg. Volume
1,652,188 - Market Cap (intraday)
31.099B - Beta (5Y Monthly) 1.08
- PE Ratio (TTM)
36.95 - EPS (TTM)
5.12 - Earnings Date (est.) Mar 4, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
309.63
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud consisting of Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; and Veeva RIM that provides regulatory information management capabilities; as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
www.veeva.com7,291
Full Time Employees
January 31
Fiscal Year Ends
Sector
Industry
Recent News: VEEV
View More
Performance Overview: VEEV
Trailing total returns as of 2/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
VEEV
15.25%
S&P 500 (^GSPC)
1.10%
1-Year Return
VEEV
18.91%
S&P 500 (^GSPC)
15.45%
3-Year Return
VEEV
6.08%
S&P 500 (^GSPC)
67.31%
5-Year Return
VEEV
33.86%
S&P 500 (^GSPC)
80.69%
Earnings Trends: VEEV
View MoreAnalyst Insights: VEEV
View MoreStatistics: VEEV
View MoreValuation Measures
As of 1/30/2026
Market Cap
33.52B
Enterprise Value
26.97B
Trailing P/E
39.75
Forward P/E
23.58
PEG Ratio (5yr expected)
0.92
Price/Sales (ttm)
11.09
Price/Book (mrq)
4.76
Enterprise Value/Revenue
8.76
Enterprise Value/EBITDA
30.02
Financial Highlights
Profitability and Income Statement
Profit Margin
27.93%
Return on Assets (ttm)
7.64%
Return on Equity (ttm)
13.72%
Revenue (ttm)
3.08B
Net Income Avi to Common (ttm)
860.33M
Diluted EPS (ttm)
5.12
Balance Sheet and Cash Flow
Total Cash (mrq)
6.64B
Total Debt/Equity (mrq)
1.27%
Levered Free Cash Flow (ttm)
1.05B
Compare To: VEEV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: VEEV
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports: VEEV
View MoreVeeva: We Think Shares are Cheap After Recent Selloff on Growth and Customer Retention Concerns
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
RatingPrice TargetVeeva: New Share Repurchase Program Sends Shares Higher, but They Still Look Undervalued
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
RatingPrice TargetVeeva: New Share Repurchase Program Sends Shares Higher, but They Still Look Undervalued
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
RatingPrice TargetVeeva Earnings: Additional Customer Loss Spooks Investors, but Broad-Based Growth Remains Strong
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
RatingPrice Target